- Home
- SRPT vs BCRX Comparison
SRPT vs BCRX Comparison
Compare SRPT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- BCRX
- Stock Information
- Founded
- SRPT 1980
- BCRX 1986
- Country
- SRPT United States
- BCRX United States
- Employees
- SRPT N/A
- BCRX N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRPT Health Care
- BCRX Health Care
- Exchange
- SRPT Nasdaq
- BCRX Nasdaq
- Market Cap
- SRPT 2.0B
- BCRX 1.8B
- IPO Year
- SRPT 1997
- BCRX 1994
- Fundamental
- Price
- SRPT $18.46
- BCRX $8.27
- Analyst Decision
- SRPT Hold
- BCRX Strong Buy
- Analyst Count
- SRPT 30
- BCRX 10
- Target Price
- SRPT $44.37
- BCRX $16.70
- AVG Volume (30 Days)
- SRPT 9.6M
- BCRX 2.2M
- Earning Date
- SRPT 08-06-2025
- BCRX 11-03-2025
- Dividend Yield
- SRPT N/A
- BCRX N/A
- EPS Growth
- SRPT N/A
- BCRX N/A
- EPS
- SRPT N/A
- BCRX N/A
- Revenue
- SRPT $2,481,531,000.00
- BCRX $557,506,000.00
- Revenue This Year
- SRPT $9.41
- BCRX $41.37
- Revenue Next Year
- SRPT N/A
- BCRX $7.56
- P/E Ratio
- SRPT N/A
- BCRX N/A
- Revenue Growth
- SRPT 64.89
- BCRX 45.85
- 52 Week Low
- SRPT $10.42
- BCRX $6.02
- 52 Week High
- SRPT $138.81
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- SRPT 48.03
- BCRX 43.55
- Support Level
- SRPT $17.95
- BCRX $8.02
- Resistance Level
- SRPT $19.61
- BCRX $8.68
- Average True Range (ATR)
- SRPT 1.20
- BCRX 0.21
- MACD
- SRPT -0.06
- BCRX 0.01
- Stochastic Oscillator
- SRPT 19.69
- BCRX 37.88
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.